安徽省5家三级甲等医院短缺药品调查分析

发布时间：2019-03-19 13:27

【摘要】：目的:为保障临床药品供应提供实证参考。方法:查阅文献并结合安徽省集中招标未中标药品情况,确定需要调查的短缺药品品种,于2013年11月-2014年10月采用问卷调查方式调查安徽省5个地区5家三级甲等医院短缺药品具体情况及短缺原因。结果:共发放问卷5份,回收有效问卷5份,有效回收率为100%。调查发现,5家三级甲等医院共有54种短缺药品,其中神经循环系统药物品种短缺最严重,所占比例为20.37%。短缺主要原因为药品价格偏低,所占比例为48.15%,其他原因有供应不足难以采购、患病人群少/用量低等。结论:针对药品短缺问题,政府部门应完善药品定价和招标政策,生产企业应提高生产研发能力,经营企业应优化网络布局,医疗卫生机构应建立权责分明的药品管理制度,以促使药品短缺现象得到缓解。
[Abstract]:Objective: to provide empirical reference for ensuring the supply of clinical drugs. Methods: referring to the literature and combining with the situation of drug not winning bid by centralized bidding in Anhui Province, the shortage of drugs needed to be investigated was determined. From November 2013 to October 2014, a questionnaire survey was conducted to investigate the specific situation and causes of shortage of drugs in 5 Grade 3A hospitals in five regions of Anhui Province. Results: a total of 5 questionnaires were sent out, 5 valid questionnaires were recovered, and the effective recovery rate was 100%. According to the survey, 54 kinds of drugs were in short supply in the five Grade 3A hospitals, of which 20.37 percent were in shortage of drugs in the neurocirculatory system. The main reason for the shortage is the low price of drugs, which accounts for 48.15% of the total. Other reasons include the shortage of supply and the difficulty of purchasing, and the low / low consumption of sick people. Conclusion: in view of the problem of drug shortage, government departments should perfect drug pricing and bidding policies, production enterprises should improve their production and R & D capacity, business enterprises should optimize the network layout, and medical and health institutions should establish clear-cut drug management systems with clear powers and responsibilities. To help ease the shortage of drugs.
【作者单位】：安徽医科大学药学院;安徽医科大学附属安庆医院;
【分类号】：R95

【参考文献】